Chugai Pharmaceutical Co., Ltd.
$25.11+0.97%(+$0.24)
TickerSpark Score
74/100
57
Valuation
100
Profitability
85
Growth
100
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHGCY research report →
52-Week Range37% of range
Low $19.50
Current $25.11
High $34.84
Companywww.chugai-pharm.co.jp
Chugai Pharmaceutical Co. , Ltd. , together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
- CEO
- Osamu Okuda
- IPO
- 2012
- Employees
- 5,026
- HQ
- Tokyo, JP
Price Chart
-3.72% · this period
Valuation
- Market Cap
- $82.65B
- P/E
- 28.83
- P/S
- 10.10
- P/B
- 6.83
- EV/EBITDA
- 18.96
- Div Yield
- 3.43%
Profitability
- Gross Margin
- 71.45%
- Op Margin
- 47.55%
- Net Margin
- 35.02%
- ROE
- 23.16%
- ROIC
- 23.03%
Growth & Income
- Revenue
- $1.32T · 12.67%
- Net Income
- $455.05B · 17.49%
- EPS
- $138.26 · 17.47%
- Op Income
- $618.80B
- FCF YoY
- -16.38%
Performance & Tape
- 52W High
- $34.84
- 52W Low
- $19.50
- 50D MA
- $26.87
- 200D MA
- $25.79
- Beta
- 0.56
- Avg Volume
- 279.57K
Get TickerSpark's AI analysis on CHGCY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CHGCY Coverage
We haven't published any research on CHGCY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHGCY Report →